Icon Wealth Partners’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-2,684
Closed -$475K 269
2020
Q1
$475K Sell
2,684
-841
-24% -$158K 0.19% 64
2019
Q4
$674K Buy
3,525
+90
+3% +$16.2K 0.21% 58
2019
Q3
$578K Sell
3,435
-438
-11% -$71.4K 0.2% 60
2019
Q2
$648K Buy
3,873
+343
+10% +$47.5K 0.23% 57
2019
Q1
$517K Buy
3,530
+922
+35% +$134K 0.19% 64
2018
Q4
$349K Sell
2,608
-704
-21% -$115K 0.17% 86
2018
Q3
$631K Sell
3,312
-53
-2% -$9.74K 0.26% 62
2018
Q2
$561K Sell
3,365
-54
-2% -$8.67K 0.24% 68
2018
Q1
$575K Buy
3,419
+1,315
+63% +$221K 0.31% 73
2017
Q4
$344K Buy
+2,104
New +$378K 0.17% 123

Other funds holding AGN

Icon Wealth Partners's AGN Position: Q2 2020 in Review

Icon Wealth Partners sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 2,684 shares — an estimated $475K sold.

Icon Wealth Partners first reported a position in AGN in Q4 2017 and held it in 10 quarters. The position peaked at $674K in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Icon Wealth Partners reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Icon Wealth Partners sold 2,684 Allergan plc shares in Q2 2020, an estimated $475K.
  • Icon Wealth Partners first reported a position in Allergan plc in Q4 2017 and held it in 10 quarters.
  • Icon Wealth Partners's Allergan plc position peaked at $674K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Icon Wealth Partners's 13F filing for Q2 2020, filed 14 Jul 2020.